Unitaid

Cervical cancer affects over 660,000 women every year, despite being one of the most preventable and treatable cancers. Early detection is essential, but traditional screening and treatment methods often remain out of reach for women in low-resource settings due to high costs and limited availability. Unitaid is working to change this. By reducing the price of HPV tests by 40% and introducing portable thermal ablation devices that cut treatment costs by 45%, we are making care more affordable and accessible. Through our initiatives, nearly 1.5 million women across 14 countries have already accessed cervical cancer screening services—a critical step toward early detection and treatment. This progress brings us closer to making cervical cancer elimination a reality for all women, everywhere. Find out more about our work: https://lnkd.in/eQ7Qzies

Every child deserves access to lifesaving treatments. Watch how the Unitaid-funded BENEFIT Kids project is revolutionizing TB care for children, ensuring better outcomes and brighter futures: https://lnkd.in/e4WQUVGf

Unitaid’s success with multidisease TB diagnostic tools offers a blueprint for AMR. We leverage this experience to introduce effective diagnostic and treatment combinations for drug-resistant infections like gonorrhea. Learn more: https://lnkd.in/e9HMZyyr

L'accès à des soins de qualité ne doit pas être un luxe. Unitaid œuvre pour que des solutions innovantes atteignent les communautés marginalisées. Ensemble, nous luttons contre les maladies évitables.

Partnerships are essential in the fight against P. vivax malaria. Through PAVE, Unitaid and partners are working to ensure lifesaving innovations like tafenoquine and point-of-care G6PD testing reach the people who need them most. Find out more: https://lnkd.in/eXdyvKYw

Maternal health challenges like preeclampsia and anemia need innovation, not stagnation. Unitaid’s funding call is a step toward sustainable solutions that prioritize equity, access, and measurable impact. Find out more: https://lnkd.in/eNgX6aqu

660,000 women are diagnosed with cervical cancer each year, yet most cases are preventable. Unitaid cut HPV test prices by 40% and treatment costs by 45% by introducing portable thermal ablation devices, helping 1.5M women access screening. Learn more: https://lnkd.in/eQ7Qzies

Unitaid’s focus on regional manufacturing is improving healthcare resilience. By supporting local production of medical oxygen, we’re building sustainable health systems that can respond to emergencies and provide routine care for women and children. 🔗 https://lnkd.in/eQ9sPS6T

Innovation in medical oxygen has the potential to transform global health, but these technologies must be tested and scaled. Unitaid is committed to ensuring these solutions reach those who need them most. Learn more: https://lnkd.in/evhMtq4j

Unitaid and the Clinton Health Access Initiative (CHAI) are working together to bridge the gap in HIV prevention with innovations like cabotegravir and lenacapavir. Our collaboration addresses barriers to affordable, long-acting options for at-risk populations. Find out more in CHAI’s HIV Market Report: https://lnkd.in/ghPvb86Q